The Organization of Teratology Information Specialists
9
2
5
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
11.1%
1 terminated/withdrawn out of 9 trials
75.0%
-11.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
Post-Marketing Study of Prucalopride Safety In Pregnancy
Role: collaborator
Apremilast Pregnancy Exposure Registry
Role: collaborator
OTIS Humira Pregnancy Registry
Role: collaborator
Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
Role: collaborator
OTIS Cimzia Pregnancy Registry
Role: collaborator
Monitoring Pregnancy and Infant Outcomes Following Tralokinumab Exposure During Pregnancy in the US and Canada - PROTECT
Role: collaborator
OTIS Vedolizumab Pregnancy Exposure Registry
Role: collaborator
Abatacept Pregnancy Exposure Registry
Role: collaborator
Post-marketing Study to Assess the Safety of CERVARIX When Used in the United States and in Canada
Role: collaborator
All 9 trials loaded